† Indicates status has not been verified in more than two years
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Safety and Efficacy of LCI699 in Cushing's Disease Patients.
An Evaluation of the Effects of LCI699 on Cortisol in Patients With Hypertension
A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism